Current Research Studies

Clinical Research

Clinical trials depend on volunteers from the community.  Samaritan’s clinical research team works with hundreds of patients in the mid-Willamette Valley, connecting them with cutting-edge research through our local principal investigators. The advancement of medicine would not be possible without the continued participation of patients in clinical research.

Samaritan’s clinical research program was established in 2008. Sponsors have included: Pfizer, Boehringer Ingelheim, Spectrum, Celgene, Genentech, Amgen, Genentech, Tragara, Bracco Diagnostic, Eisai, PUMA, Novartis, Incyte, Pharmatech, Medtronic, St. Jude Medical and the National Institutes of Health.

  • National Institute of Health and Federal Drug Administration registration number: IRB00005278.
  • Institutional Organization Number (IORG) is IORG0004448.
  • We are a research affiliate of UCSF for The Alliance for Clinical Trials in Oncology.

For more information, email clinicalresearch@samhealth.org or call 541-768-4352.

 

Current Studies

Title More Information

Blood Purification for the Treatment of Pathogen Associated Shock (PURIFY-RCT)

Principal Investigator: Brian Delmonaco, MD

 For more information on this trial.

Assessment of Implementation Methods in Sepsis and Respiratory Failure (AIMS)

Principal Investigator: Brian Delmonaco, MD

  Email clinicalresearch@samhealth.org

COVID-19 Specimen Biobank

Principal Investigator: Adam Brady, MD

 Email clinicalresearch@samhealth.org

Breast

Title More Information

Making Informed Choices on Incorporating Chemoprevention Into Care (MiCHOICE)

Principal Investigator: Rachel Shirley, DO

 For more information on this trial.
A Study of Imlunestrant Versus Standard Endocrine Therapy in Participants With Early Breast Cancer (EMBER-4)

Principal Investigator: Robert Davis, MD		 For more information on this trial.

Lung

Title More Information

Lung Cancer Screening Program

Principal Investigator: Vanessa Mizak, NP, and Brian Delmonaco, MD

 Email: clinicalresearch@samhealth.org

Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)

Principal Investigator: John Strother, MD

 For more information on this trial.

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, ALCHEMIST Chemo-IO Study

Principal Investigator: John Strother, MD

 For more information on this trial.

Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)

Principal Investigator: John Strother, MD

 For more information on this trial.
Lung Cancer Companion Diagnostic
 
Principal Investigator: Tomer Pelleg, DO		 Email clinicalresearch@samhealth.org


Other

Title More Information
Multiple Metastatic Tumors

Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas or Multiple Myeloma (The MATCH Screening Trial)

Principal Investigator: John Strother, MD

 For more information on this trial.
Sarcoma

Incisional Negative Pressure Wound Therapy for Preoperatively Irradiated Lower Extremity Soft Tissue Sarcoma Wounds

Principal Investigator: Nicholas Tedesco, DO

 For more information on this trial.
Orthopedic Tumor Surgery

Orthopedic Tumor Data Registry

Principal Investigator: Nicholas Tedesco, DO

 Email: clinicalresearch@samhealth.org

realMIND: Observational Study of Patients With Relapsed or Refractory DLBCL Starting Second- or Third-line Therapy (realMIND)

Principal Investigator: Robert Davis, MD

 For more information on this trial.
Metastatic Bone Reconstructions

Principal Investigator: Nicholas Tedesco, DO

 Email: clinicalresearch@samhealth.org 
Multiple Solid Tumor Cancer Detection  

Principal Investigator: John Strother, MD		 Email: clinicalresearch@samhealth.org
Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors

Principal Investigator: John Strother, MD		 For more information on this trial.

 

Title More Information

Study of Inclisiran to Prevent Cardiovascular (CV) Events in Participants With Established Cardiovascular Disease (VICTORION-2P)

Principal Investigator: Jeremy Warner, DO

 For more information on this trial.

 

Title More Information

A Study of Baricitinib in Participants With Rheumatoid Arthritis (RA-BRANCH)

Principal Investigator: Jonathan Jones, MD

 For more information on this trial.

Corrona Rheumatoid Arthritis (RA) Drug Safety & Effectiveness Registry

Principal Investigator: Jonathan Jones, MD

  For more information on this trial.

Rheumatology Biorepository

Principal Investigator: Jonathan Jones, MD

  For more information on this trial.

A Study to Determine the Efficacy and Safety of Deucravacitinib Compared With Placebo in Participants With Active Psoriatic Arthritis (PsA) Who Are Naïve to Biologic Disease-modifying Anti-rheumatic Drugs

Principal Investigator: Jonathan Jones, MD

  For more information on this trial.

 

Title More Information

Benign Soft Tissue Tumor Resection

Principal Investigators: Jared Sanderford, DO, and Nicholas Tedesco, DO

 Email: clinicalresearch@samhealth.org
Use of Empagliflozin to Treat Prediabetes – a Randomized, Double-blind, Placebo-controlled 13-week Intervention Trial

Principal Investigators: Sean Newsom, PhD, and Matthew Robinson, Ph.D. (Oregon State University)		 For more information on this trial.

For more information about clinical research at Samaritan, contact us at 541-768-4352 or clinicalresearch@samhealth.org.